VP Harris, DEA, FDA Eye Cannabis: Key Changes Ahead, Here’s What One Expert Predicts
Vice President Harris’s urgent call to the DEA to expedite the rescheduling of cannabis marks a crucial turning point in national drug policy, as analyzed in a comprehensive equity research report by…